Effects of repetitive transcranial magnetic stimulation in multiple sclerosis: A systematic review and meta-analysis.
Xiao Chen, Lu Yin, Yun An...
https://pubmed.ncbi.nlm.nih.gov/35123289/Actively Recruiting
Led by University of New Mexico · Updated on 2026-07-15
60
Participants Needed
1
Research Sites
N/A
Total Duration
This trial investigates whether accelerated intermittent theta burst stimulation iTBS, a rapid outpatient brain stimulation using magnetic fields, can help reduce symptoms such as brain fog, depression, and anxiety in adults with Long COVID. The study is a randomized, sham-controlled, phase 2 trial aiming to evaluate the effectiveness and feasibility of iTBS in treating these neuropsychiatric symptoms and their association with inflammatory brain chemicals. Participants receive either sham or active iTBS targeting the left dorsolateral prefrontal cortex, delivered 5 times per day over 10 days. The trial includes a blinded phase with 25 sessions and an open-label extension with 25 active sessions. Sham stimulation mimics the sensation of active treatment without magnetic effects, using mild electrical skin stimulation to maintain blinding. During the study, participants complete symptom surveys, cognitive tests, and MRI scans at baseline, mid-treatment, and end-of-treatment. Researchers measure symptom changes with the Symptom Burden Questionnaire and assess brain inflammation through choline levels. The total study duration spans 2 weeks of treatment, with ongoing monitoring to evaluate neuropsychiatric improvements and brain imaging findings.
CONDITIONS
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
C
Crystal Garcia
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of New Mexico
Lead Sponsor
The Mind Research Network
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Active accelerated iTBS | Sham accelerated iTBS |
|---|---|---|
| What it is | A series of noninvasive brain stimulation sessions using intermittent theta burst stimulation (iTBS) designed to target and modulate neural activity. | A control procedure simulating iTBS sessions but without delivering active brain stimulation. |
| Role in the trial | Evaluated as the investigational treatment to assess its ability to improve cognitive difficulties and reduce neuroinflammation in long COVID/PASC. | Serves as the placebo-like inactive control for comparison with active treatment. |
| Primary use | Investigational use to potentially improve cognitive symptoms and modify neural inflammation in adults with long COVID/PASC and brain fog. | Placebo-like comparator to measure outcomes against the active investigational treatment. |
| How it is given or performed | Noninvasive magnetic pulses are delivered to the scalp in repeated theta burst patterns across a series of sessions. | Sessions reproduce the sounds and procedures of iTBS but without active magnetic stimulation. |
| Evidence status | Evidence supporting rTMS and iTBS for cognitive symptoms in long COVID is emerging, with initial studies showing potential improvement in fatigue and cognition, but robust, large-scale evidence is still needed. | No therapeutic efficacy is expected from sham stimulation; serves as an inactive comparator in studies evaluating true intervention effects. |
| Important limitations | The role of iTBS for cognitive symptoms in long COVID/PASC is still under investigation; studies to date are small, lack long-term follow-up, and often vary in technique and outcome measures. Results may not generalize to all patients with brain fog or cognitive symptoms. | Sham stimulation results cannot be interpreted as a true treatment effect and serve only as a control for active intervention. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 2 weeks
Participants receive active or sham accelerated intermittent theta burst stimulation (iTBS) targeting the brain over 10 days, with 5 sessions per day. After the blinded phase, participants may receive additional active treatment in an open-label extension.
Daily visits for 10 days with 5 sessions per day
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Xiao Chen, Lu Yin, Yun An...
https://pubmed.ncbi.nlm.nih.gov/35123289/Carolin Reischauer, Andreas Gutzeit, Christoph Neuwirth...
https://pubmed.ncbi.nlm.nih.gov/30317156/K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941/Maura Boldrini, Peter D Canoll, Robyn S Klein
https://pubmed.ncbi.nlm.nih.gov/33769431/Andrew R Mayer, David D Stephenson, Christopher J Wertz...
https://pubmed.ncbi.nlm.nih.gov/31456319/Valeria Sasso, Elisa Bisicchia, Laura Latini...
https://pubmed.ncbi.nlm.nih.gov/27301743/Timothy B Meier, Patrick S F Bellgowan, Rashmi Singh...
https://pubmed.ncbi.nlm.nih.gov/25730545/Eleanor J Cole, Angela L Phillips, Brandon S Bentzley...
https://pubmed.ncbi.nlm.nih.gov/34711062/Nobuyuki Sasaki, Masato Yamatoku, Tomoya Tsuchida...
https://pubmed.ncbi.nlm.nih.gov/36861061/Jiemei Chen, Yan Zeng, Jiena Hong...
https://pubmed.ncbi.nlm.nih.gov/36455674/University of New Mexico
Lead Sponsor
The Mind Research Network
Collaborating Sponsor